Xilio Therapeutics (XLO) EBT Margin Growth (1y) (2025 - 2026)

Xilio Therapeutics (XLO) EBT Margin Growth (1y) (2025 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin Growth (1y) (Qtr)
1 Oculis Holding AG 67,102.16 Bn 67,101.87 Bn - -
2 Nanobiotix 1,913.50 Bn 1,913.44 Bn - -
3 Akari Therapeutics 959.56 Bn 959.56 Bn - -
4 BeOne Medicines 472.39 Bn 467.60 Bn 1.35 Bn 1,526.00
5 Vertex Pharmaceuticals 122.08 Bn 114.83 Bn 2.59 Bn 1,558.00
6 Regeneron Pharmaceuticals 69.98 Bn 61.22 Bn 3.31 Bn -683.00
7 Belite Bio 62.34 Bn 62.34 Bn - -
8 Argenx Se 55.97 Bn 50.78 Bn 1.41 Bn 452.00
9 Alnylam Pharmaceuticals 37.47 Bn 34.46 Bn 959.66 Mn 1,939.00
10 Xilio Therapeutics 147.13 Mn -3.17 Mn - 36,302.00

Historic Data

Download Data
DateValue
Mar 31, 2026 36,302.00
Dec 31, 2025 72,022.00
Sep 30, 2025 64,622.00
Jun 30, 2025 45,308.00